extremely significantP <0.0001
Except for the AD vaccine group, the serum from all the recombinant ADDomer-VLP vaccine groups exhibited extremely significant differences ( P <0.0001) in ND50 on day 35 compared to day 0.
Except for the AD vaccine group, the serum from all the recombinant ADDomer-VLP vaccine groups exhibited extremely significant differences ( P <0.0001) in ND50 on day 35 compared to day 0.